FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155233786> ?p ?o ?g. }

• W2155233786 endingPage "2775" @default.
• W2155233786 startingPage "2768" @default.
• W2155233786 abstract "Purpose Oversuppression of bone turnover can be a critical factor in the pathogenesis of osteonecrosis of the jaw (ONJ). We investigated N-telopeptide of type I collagen (NTX) and bone-specific alkaline phosphatase (BAP) as potential predictors of ONJ onset. Patients and Methods Patients with ONJ and available stored serum were identified retrospectively from the institutional databases. Four approximate points were examined: point of ONJ diagnosis and 12, 6, and 1 month before the diagnosis. NTX and BAP were measured using enzyme-linked immunosorbent assays and examined as possible predictors of ONJ. Results From March 1998 to September 2009, we identified 122 patients with ONJ. Of these, 56 (46%) had one or more serum samples available. Overall, 55 patients (98%) received bisphosphonates. Using the exact dates, no obvious patterns in either NTX or BAP were noted. Similarly, using the ordinal points, no evidence of suppression of NTX or BAP over time was seen. The consecutive median values were as follows: The median NTX values were 8.0 nmol/L (range 3.8 to 32.9) at 12 months before ONJ; 9.5 nmol/L (range 4.7 to 42.7) at 6 months; 9.5 nmol/L (range 4.5 to 24.6) at 1 month, and 10.4 nmol/L (range 4.4 to 32.5) at the ONJ diagnosis. The median BAP values were BAP 18.0 U/L (range 7.0 to 74) at 12 months before ONJ; 18.0 U/L (range 4.0 to 134) at 6 months; 14.0 U/L (range 4.0 to 132) at 1 month, and 18.0 U/L (range 0.7 to 375) at the ONJ diagnosis. Only 2 patients (4%) had NTX and 17 (30%) had BAP below the normal range at the ONJ diagnosis. Conclusions In the present large retrospective study, no trends were seen in the NTX and BAP levels before the ONJ diagnosis. Oversuppression of bone turnover can be a critical factor in the pathogenesis of osteonecrosis of the jaw (ONJ). We investigated N-telopeptide of type I collagen (NTX) and bone-specific alkaline phosphatase (BAP) as potential predictors of ONJ onset. Patients with ONJ and available stored serum were identified retrospectively from the institutional databases. Four approximate points were examined: point of ONJ diagnosis and 12, 6, and 1 month before the diagnosis. NTX and BAP were measured using enzyme-linked immunosorbent assays and examined as possible predictors of ONJ. From March 1998 to September 2009, we identified 122 patients with ONJ. Of these, 56 (46%) had one or more serum samples available. Overall, 55 patients (98%) received bisphosphonates. Using the exact dates, no obvious patterns in either NTX or BAP were noted. Similarly, using the ordinal points, no evidence of suppression of NTX or BAP over time was seen. The consecutive median values were as follows: The median NTX values were 8.0 nmol/L (range 3.8 to 32.9) at 12 months before ONJ; 9.5 nmol/L (range 4.7 to 42.7) at 6 months; 9.5 nmol/L (range 4.5 to 24.6) at 1 month, and 10.4 nmol/L (range 4.4 to 32.5) at the ONJ diagnosis. The median BAP values were BAP 18.0 U/L (range 7.0 to 74) at 12 months before ONJ; 18.0 U/L (range 4.0 to 134) at 6 months; 14.0 U/L (range 4.0 to 132) at 1 month, and 18.0 U/L (range 0.7 to 375) at the ONJ diagnosis. Only 2 patients (4%) had NTX and 17 (30%) had BAP below the normal range at the ONJ diagnosis. In the present large retrospective study, no trends were seen in the NTX and BAP levels before the ONJ diagnosis." @default.
• W2155233786 created "2016-06-24" @default.
• W2155233786 creator A5008043617 @default.
• W2155233786 creator A5011803946 @default.
• W2155233786 creator A5012521956 @default.
• W2155233786 creator A5022311156 @default.
• W2155233786 creator A5022759974 @default.
• W2155233786 creator A5023577254 @default.
• W2155233786 creator A5034225982 @default.
• W2155233786 creator A5036938501 @default.
• W2155233786 creator A5047713528 @default.
• W2155233786 creator A5060865593 @default.
• W2155233786 creator A5067642403 @default.
• W2155233786 creator A5069656105 @default.
• W2155233786 date "2012-12-01" @default.
• W2155233786 modified "2023-09-27" @default.
• W2155233786 title "Serum N-Telopeptide and Bone-Specific Alkaline Phosphatase Levels in Patients With Osteonecrosis of the Jaw Receiving Bisphosphonates for Bone Metastases" @default.
• W2155233786 cites W1768011742 @default.
• W2155233786 cites W1995559440 @default.
• W2155233786 cites W2002094338 @default.
• W2155233786 cites W2004931703 @default.
• W2155233786 cites W2010663401 @default.
• W2155233786 cites W2015489649 @default.
• W2155233786 cites W2028684870 @default.
• W2155233786 cites W2033712867 @default.
• W2155233786 cites W2044971350 @default.
• W2155233786 cites W2055708086 @default.
• W2155233786 cites W2072396430 @default.
• W2155233786 cites W2093717174 @default.
• W2155233786 cites W2097110735 @default.
• W2155233786 cites W2107118598 @default.
• W2155233786 cites W2115871403 @default.
• W2155233786 cites W2115962082 @default.
• W2155233786 cites W2122429800 @default.
• W2155233786 cites W2122467899 @default.
• W2155233786 cites W2129220952 @default.
• W2155233786 cites W2133503719 @default.
• W2155233786 cites W2137654510 @default.
• W2155233786 cites W2140824213 @default.
• W2155233786 cites W2142234592 @default.
• W2155233786 cites W2142616794 @default.
• W2155233786 cites W2146941412 @default.
• W2155233786 cites W2149520257 @default.
• W2155233786 cites W2150904792 @default.
• W2155233786 cites W2152409486 @default.
• W2155233786 cites W2163852287 @default.
• W2155233786 cites W2165011173 @default.
• W2155233786 cites W2170309090 @default.
• W2155233786 cites W2170565025 @default.
• W2155233786 cites W2316096113 @default.
• W2155233786 cites W4376595748 @default.
• W2155233786 cites W85118458 @default.
• W2155233786 doi "https://doi.org/10.1016/j.joms.2011.12.028" @default.
• W2155233786 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22330331" @default.
• W2155233786 hasPublicationYear "2012" @default.
• W2155233786 type Work @default.
• W2155233786 sameAs 2155233786 @default.
• W2155233786 citedByCount "15" @default.
• W2155233786 countsByYear W21552337862013 @default.
• W2155233786 countsByYear W21552337862014 @default.
• W2155233786 countsByYear W21552337862015 @default.
• W2155233786 countsByYear W21552337862016 @default.
• W2155233786 countsByYear W21552337862019 @default.
• W2155233786 countsByYear W21552337862020 @default.
• W2155233786 countsByYear W21552337862021 @default.
• W2155233786 countsByYear W21552337862023 @default.
• W2155233786 crossrefType "journal-article" @default.
• W2155233786 hasAuthorship W2155233786A5008043617 @default.
• W2155233786 hasAuthorship W2155233786A5011803946 @default.
• W2155233786 hasAuthorship W2155233786A5012521956 @default.
• W2155233786 hasAuthorship W2155233786A5022311156 @default.
• W2155233786 hasAuthorship W2155233786A5022759974 @default.
• W2155233786 hasAuthorship W2155233786A5023577254 @default.
• W2155233786 hasAuthorship W2155233786A5034225982 @default.
• W2155233786 hasAuthorship W2155233786A5036938501 @default.
• W2155233786 hasAuthorship W2155233786A5047713528 @default.
• W2155233786 hasAuthorship W2155233786A5060865593 @default.
• W2155233786 hasAuthorship W2155233786A5067642403 @default.
• W2155233786 hasAuthorship W2155233786A5069656105 @default.
• W2155233786 hasConcept C125870589 @default.
• W2155233786 hasConcept C126322002 @default.
• W2155233786 hasConcept C131075544 @default.
• W2155233786 hasConcept C141071460 @default.
• W2155233786 hasConcept C160160445 @default.
• W2155233786 hasConcept C170033053 @default.
• W2155233786 hasConcept C181199279 @default.
• W2155233786 hasConcept C185592680 @default.
• W2155233786 hasConcept C199343813 @default.
• W2155233786 hasConcept C2776541429 @default.
• W2155233786 hasConcept C2777251235 @default.
• W2155233786 hasConcept C2777556957 @default.
• W2155233786 hasConcept C55493867 @default.
• W2155233786 hasConcept C71924100 @default.
• W2155233786 hasConcept C90924648 @default.
• W2155233786 hasConceptScore W2155233786C125870589 @default.
• W2155233786 hasConceptScore W2155233786C126322002 @default.
• W2155233786 hasConceptScore W2155233786C131075544 @default.
• W2155233786 hasConceptScore W2155233786C141071460 @default.

• next